Global Pharmaceuticals Industry Profile & Value Chain Analysis
Global Pharmaceuticals Industry Profile & Value Chain Analysis
SUMMARY
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
The value/supply chain analysis reveals the business activities which comprise the global pharmaceuticals market’s value/supply chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value/supply chain. Key value/supply chain stages analyzed include raw ingredients, manufacturing, buyers and end-users.
SYNOPSIS
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
KEY HIGHLIGHTS
SUMMARY
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
The value/supply chain analysis reveals the business activities which comprise the global pharmaceuticals market’s value/supply chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value/supply chain. Key value/supply chain stages analyzed include raw ingredients, manufacturing, buyers and end-users.
SYNOPSIS
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
- The global pharmaceuticals market had total revenues of $946.1bn in 2016, representing a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016.
- The US, Japan and China are the largest global pharmaceutical markets followed by the four biggest European markets: France, Germany, the UK, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.
- The patent cliff has caused revenue losses for many companies. The sales of Pfizer, Novartis and Merck & Co. fell when they lost their patents for Lipitor, Diovan and Singulair, respectively. AstraZeneca has been particularly affected by the patent cliff.
- Raw ingredients in pharmaceuticals are very wide-ranging in scope but can be loosely combined into groups. Pharmaceutical companies are responsible for sourcing ingredients.
- Manufacturing of pharmaceutical drugs is typically undertaken by large, international pharmaceutical companies.
- Health care providers make the majority of pharmaceutical purchases, but pharmacies and retailers remain important buyers for pharmaceutical companies.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
- Quickly and easily identify the key stages and sub-stages of the global pharmaceuticals market value/supply chain
- See examples of companies active at each stage of the global pharmaceuticals market value/supply chain
- Examine trends and burning issues impacting the global pharmaceuticals market value/supply chain
- What was the size of the global pharmaceuticals market by value in 2016?
- What will be the size of the global pharmaceuticals market in 2021?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?
- What are the key stages of the global pharmaceuticals market value/supply chain?
Executive Summary
Value chain analysis
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Value Chain Analysis
Pharmaceuticals Market complete value chain overview
Raw Ingredients
Manufacturing
Buyers
End-Users
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Johnson & Johnson
Novartis AG
Pfizer Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
Value chain analysis
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Value Chain Analysis
Pharmaceuticals Market complete value chain overview
Raw Ingredients
Manufacturing
Buyers
End-Users
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Johnson & Johnson
Novartis AG
Pfizer Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
LIST OF TABLES
Table 1: Global pharmaceuticals market value: $ billion, 2012-16
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Global pharmaceuticals market share: % share, by value, 2016
Table 4: Global pharmaceuticals market value forecast: $ billion, 2016-21
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Johnson & Johnson: key facts
Table 10: Johnson & Johnson: key financials ($)
Table 11: Johnson & Johnson: key financial ratios
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
Table 1: Global pharmaceuticals market value: $ billion, 2012-16
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Global pharmaceuticals market share: % share, by value, 2016
Table 4: Global pharmaceuticals market value forecast: $ billion, 2016-21
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Johnson & Johnson: key facts
Table 10: Johnson & Johnson: key financials ($)
Table 11: Johnson & Johnson: key financial ratios
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
LIST OF FIGURES
Figure 1: Pharmaceuticals Market complete value chain overview
Figure 2: Pharmaceuticals Market complete value chain with active companies
Figure 3: Raw Ingredients - Overview
Figure 4: Manufacturing - Overview
Figure 5: Buyers - Overview
Figure 6: End-Users - Overview
Figure 7: Global pharmaceuticals market value: $ billion, 2012-16
Figure 8: Global pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 9: Global pharmaceuticals market share: % share, by value, 2016
Figure 10: Global pharmaceuticals market value forecast: $ billion, 2016-21
Figure 11: Forces driving competition in the global pharmaceuticals market, 2016
Figure 12: Drivers of buyer power in the global pharmaceuticals market, 2016
Figure 13: Drivers of supplier power in the global pharmaceuticals market, 2016
Figure 14: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2016
Figure 15: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2016
Figure 16: Drivers of degree of rivalry in the global pharmaceuticals market, 2016
Figure 17: Bayer AG: revenues & profitability
Figure 18: Bayer AG: assets & liabilities
Figure 19: Johnson & Johnson: revenues & profitability
Figure 20: Johnson & Johnson: assets & liabilities
Figure 21: Novartis AG: revenues & profitability
Figure 22: Novartis AG: assets & liabilities
Figure 23: Pfizer Inc.: revenues & profitability
Figure 24: Pfizer Inc.: assets & liabilities
Figure 1: Pharmaceuticals Market complete value chain overview
Figure 2: Pharmaceuticals Market complete value chain with active companies
Figure 3: Raw Ingredients - Overview
Figure 4: Manufacturing - Overview
Figure 5: Buyers - Overview
Figure 6: End-Users - Overview
Figure 7: Global pharmaceuticals market value: $ billion, 2012-16
Figure 8: Global pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 9: Global pharmaceuticals market share: % share, by value, 2016
Figure 10: Global pharmaceuticals market value forecast: $ billion, 2016-21
Figure 11: Forces driving competition in the global pharmaceuticals market, 2016
Figure 12: Drivers of buyer power in the global pharmaceuticals market, 2016
Figure 13: Drivers of supplier power in the global pharmaceuticals market, 2016
Figure 14: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2016
Figure 15: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2016
Figure 16: Drivers of degree of rivalry in the global pharmaceuticals market, 2016
Figure 17: Bayer AG: revenues & profitability
Figure 18: Bayer AG: assets & liabilities
Figure 19: Johnson & Johnson: revenues & profitability
Figure 20: Johnson & Johnson: assets & liabilities
Figure 21: Novartis AG: revenues & profitability
Figure 22: Novartis AG: assets & liabilities
Figure 23: Pfizer Inc.: revenues & profitability
Figure 24: Pfizer Inc.: assets & liabilities
